Patents by Inventor Jeff Vierstra

Jeff Vierstra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nuclease-mediated regulation of gene expression
    Patent number: 10619154
    Abstract: The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: April 14, 2020
    Assignees: Sangamo Therapeutics, Inc., University of Washington
    Inventors: Andreas Reik, John A. Stamatoyannopoulos, Jeff Vierstra
  • NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
    Publication number: 20180237768
    Abstract: The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
    Type: Application
    Filed: March 21, 2018
    Publication date: August 23, 2018
    Inventors: Andreas Reik, John A. Stamatoyannopoulos, Jeff Vierstra
  • Nuclease-mediated regulation of gene expression
    Patent number: 9957501
    Abstract: The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: May 1, 2018
    Assignees: Sangamo Therapeutics, Inc., University Of Washington
    Inventors: Andreas Reik, John A. Stamatoyannopoulos, Jeff Vierstra